Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's …
MA Daulatzai - Journal of neuroscience research, 2017 - Wiley Online Library
Aging, hypertension, diabetes, hypoxia/obstructive sleep apnea (OSA), obesity, vitamin
B12/folate deficiency, depression, and traumatic brain injury synergistically promote diverse …
B12/folate deficiency, depression, and traumatic brain injury synergistically promote diverse …
Matrix metalloproteinases and blood-brain barrier disruption in acute ischemic stroke
SE Lakhan, A Kirchgessner, D Tepper… - Frontiers in …, 2013 - frontiersin.org
Ischemic stroke continues to be one of the most challenging diseases in translational
neurology. Tissue plasminogen activator (tPA) remains the only approved treatment for …
neurology. Tissue plasminogen activator (tPA) remains the only approved treatment for …
Molecular mechanisms of apoptosis in cerebral ischemia: multiple neuroprotective opportunities
VP Nakka, A Gusain, SL Mehta, R Raghubir - Molecular neurobiology, 2008 - Springer
Cerebral ischemia/reperfusion (I/R) injury triggers multiple and distinct but overlapping cell
signaling pathways, which may lead to cell survival or cell damage. There is overwhelming …
signaling pathways, which may lead to cell survival or cell damage. There is overwhelming …
Exendin-4, a glucagon-like peptide-1 receptor agonist, provides neuroprotection in mice transient focal cerebral ischemia
S Teramoto, N Miyamoto, K Yatomi… - Journal of Cerebral …, 2011 - journals.sagepub.com
Glucagon-like peptide-1 (GLP-1) is an incretin hormone known to stimulate glucose-
dependent insulin secretion. The GLP-1 receptor agonist, exendin-4, has similar properties …
dependent insulin secretion. The GLP-1 receptor agonist, exendin-4, has similar properties …
Cilostazol protects against brain white matter damage and cognitive impairment in a rat model of chronic cerebral hypoperfusion
T Watanabe, N Zhang, M Liu, R Tanaka, Y Mizuno… - Stroke, 2006 - Am Heart Assoc
Background and Purpose—White matter lesions contribute to cognitive impairment in
poststroke patients. The present study was designed to assess the neuroprotective …
poststroke patients. The present study was designed to assess the neuroprotective …
Phosphodiesterase 3 inhibitor cilostazol induces migraine-like attacks via cyclic AMP increase
The initiating mechanisms of migraine attacks are very complex but may involve the cyclic
AMP signalling pathway. It is unknown whether intracellular cyclic AMP accumulation …
AMP signalling pathway. It is unknown whether intracellular cyclic AMP accumulation …
Cilostazol modulates autophagic degradation of β-amyloid peptide via SIRT1-coupled LKB1/AMPKα signaling in neuronal cells
SY Park, HR Lee, WS Lee, HK Shin, HY Kim, KW Hong… - PloS one, 2016 - journals.plos.org
A neuroprotective role of autophagy mediates the degradation of β-amyloid peptide (Aβ) in
Alzheimer's disease (AD). The previous study showed cilostazol modulates autophagy by …
Alzheimer's disease (AD). The previous study showed cilostazol modulates autophagy by …
Development of therapeutics that induce mitochondrial biogenesis for the treatment of acute and chronic degenerative diseases
RB Cameron, CC Beeson… - Journal of medicinal …, 2016 - ACS Publications
Mitochondria have various roles in cellular metabolism and homeostasis. Because
mitochondrial dysfunction is associated with many acute and chronic degenerative …
mitochondrial dysfunction is associated with many acute and chronic degenerative …
Cilostazol prevents amyloid β peptide25‐35‐induced memory impairment and oxidative stress in mice
M Hiramatsu, O Takiguchi… - British journal of …, 2010 - Wiley Online Library
BACKGROUND AND PURPOSE Cilostazol may be effective in dementia associated with a
cerebral ischaemia. In this study, we examined whether it exerts beneficial effects on …
cerebral ischaemia. In this study, we examined whether it exerts beneficial effects on …
Antithrombotic therapy for secondary prevention in patients with stroke or transient ischemic attack: A multiple treatment network meta-analysis of randomized …
D Tornyos, A Komócsi, A Bálint, P Kupó… - Plos One, 2022 - journals.plos.org
Objective As stroke represents one of the leading causes of mortality and disability
worldwide, we aimed to determine the preventive effect of different antiplatelet therapies …
worldwide, we aimed to determine the preventive effect of different antiplatelet therapies …